International Clinical Trials Day provided the chance to recognise the many people contributing to our life-changing clinical trials. Two key events were staged to mark the day, including a presentation in the Kolling auditorium from leading clinical trial investigators, and a public display within Royal North Shore Hospital.  More than 300 trials are underway across Northern Sydney including .....
Read more

Check out our latest newsletter Researchers target sleep for muscle pain relief Landmark clinical trial to improve lung cancer treatment Pioneering Muscle Map project receives funding support Travel awards for emerging research leaders And much more:  Click here:
Read more

Five emerging researchers will have the chance to develop their skills and raise the international profile of the Kolling Institute thanks to generous funding from the Skipper Jacobs Charitable Trust. Academic Director Professor James Elliott said a total of $40,000 will be shared by the early-to-mid career researchers to increase their research impact and strengthen their collaborations. Pablo Cru.....
Read more

An innovative tool which could revolutionise the detection and treatment of musculoskeletal and neurological conditions will be further developed following a $230,000 gift. The donation was made following a campaign by the University of Sydney’s Advancement team and the NORTH Foundation to support the world’s first open-source dataset of whole-body muscle composition. The Kolling Institute’s Academ.....
Read more

More than 80 top national and international scientists converged on the Kolling Institute for the 4th Optogenetics Australia meeting, featuring the very latest light technologies driving research. The event attracted dynamic keynote speakers from the USA, Europe and China, and leading research institutions across Australia. Chair of Optogenetics Australia and senior Kolling Institute pain medicine .....
Read more

In a crucial step towards a better understanding of Meniere’s disease, researchers at the Kolling Institute and the University of Sydney have discovered a gene mutation which could greatly inform future treatment of the disease. Meniere’s is a rare inner ear disease associated with sensorineural hearing loss, vertigo and debilitating tinnitus. There is currently no cure with treatment largely aimed.....
Read more

For the past 20 years, Professor Sarah Hilmer has dedicated her career to optimising medicine use for older people and has achieved recognition as a national and world leader in geriatric pharmacology. Not only has the Royal North Shore Hospital clinical pharmacologist and geriatrician set about improving medication practices for older people, but she has long advocated for ‘age-friendly’ clinical .....
Read more

Internationally respected clinical academic Professor Paul Glare has been named a Member of the Order of Australia for his significant service to medicine in the fields of pain management and palliative care. Professor Glare is a specialist physician in pain medicine and senior researcher with the Kolling Institute. He is the Director of the Michael J Cousins Pain Management Research Centre at Roy.....
Read more

Two emerging leaders within the Kolling Institute’s Ageing and Pharmacology Lab are gaining attention for their impressive work to improve the quality use of medications. Dr Nashwa Masnoon and Dr Kenji Fujita have received prestigious awards at the annual meeting of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT). Nashwa, who is also a pharmacist at .....
Read more

An exciting partnership between AGRF Ltd (Australian Genome Research Facility) and the University of Sydney and the Kolling Institute will help strengthen genomic capabilities. The partnership will see a specialised team and cutting-edge technology located within the institute to progress research in this increasingly crucial field. As Australia’s largest provider of genomic services, AGRF supports.....
Read more